Chemotherapeutics Flashcards
(36 cards)
Trastuzumab (Herceptin)
Monoclonal Antibody: against HER2. For HER2 positive breast cancer (HER2 gene encodes growth factor HER2 - overexpressed in 25-30% breast cancers). Use in combination with chemo, improves outcomes.
Imatinib (Bleevec)
Tyrosine kinase (TK) inhibitor. For sustained remission of chronic myeloid leukemia (CML). Inhibits abnormal TK that drives proliferation. Tx: nausea, vomiting, diarrhea, edema, muscle cramps, rash, neutropenia, thrombocytopenia.
Gefitinib (Iressa)
TK inhibitor. Blocks growth signals mediated by TK (especially TK associated w/ EGF). For advanced non-small cell lung cancer. Only 10% of patients responsive, so identify people w/ EGF gene mutation.
Bevacizumab (Avastin)
Antibody. Targets VEGF. Inhibits angiogenesis.
Sunitinib (Sutent)
TK inhibitor. NEW! Targets VEGF. Inhibits angiogenesis.
Sorafenib (Nexavar)
Similar to Sunitinib. Inhibits angiogenesis.
Suberoylanilide Hydroxamic Acid (Vorinostat)
Histone deacteylase inhibitor (HDACi). Keeps histones acetylated and transcriptionally active to reactivate down regulated tumor suppressor genes. Inhibits cancer growth epigenetically
Azacytidine and Decitabine
Inhibit DNA methylation (Epigenetic) - Reactivate down regulated tumor suppressor genes. Inhibits cancer growth.
Methylguanine Methyltransferase (MGMT)
Repairs alkylating damage to DNA. Helps repair normal cells. glioblastomas w/ methylated (silenced) MGMT more likely to have successful treatment by Temozolomide
Temozolomide
Alkylating agent. Damages DNA to kill cancer cells esp. glioblastoma. Use w/ methylated MGMT to make more responsive
Sarcosine
Amino acid (derivative of glycine). Potentially important metabolic intermediary of prostate cancer cell invasion and metastasis. Measure for aggressiveness. Tells whether someone will need aggressive treatment or not. Lowest in BPH, higher in Prostatic Cancer, Highest with Metastasis.
Serotonin receptor antagonists: Dolasetron (Anzemet) and Palonosetron (Aloxi, T1/2=40 hrs.)
Prevent nausea and vomiting from chemo. Side effects: headache, dizzyness, diarrhea, constipation
Corticosteroids: Dexamethasone
Prevent nausea and vomiting from chemo.
Chlorambucil
Alkylating agent. Non cycle active. Abs. Oral. Least toxic alkylating agent. For chronic leukemias. Non cycle active.
Cyclophosphamide
Alkylating agent. Non cycle active. Requires metabolic activation by liver. Tx: Hair loss, liver tx.
Carmustin (BCNU)
Alkylating agent. Non cycle active. Abs. IV. Lipid soluble - Dist. to CSF for CNS tumors.
Busulfan
Alkylating agent. Non cycle active. For myelosuppression. Tx: Little to GI.
Gemcitabine
Non cycle active. Inhibits DNA synthesis, and alters DNA template. Effective agains solid tumors.
Methotrexate (MTX)
Antimetabolite: Folic acid analog. Inhibits dihydrofolate reductase which decreases THF, thereby inhibiting 1 C transfers and DNA synthesis. Renal E. Contraindicated in people w/ renal function impairment. Cycle active drug.
Folinic Acid
Recues MTX induced host toxicity. Metabolizes to THF w/o using dihydrofolate reductase.
6-Mercaptopurine and Thioguanine
Purine analogs. Inhibit multiple steps in purine nucleotide synthesis. Must be metabolized to be active, then inhibit IMP. Cycle active, decrease DNA synthesis.
5-Fluorouracil (5-FU)
Pyrimidine analog. Must be metabolized into mono-P. Inhibits thymidylate synthetase conversion of dUMP to TMP. Cycle active, decreases DNA synthesis. Tx: Hair loss
Cytarabine
Pyrimidine analog. Must be metabolized into mono-P.
Paclitaxel (Taxol), Vincristine, Vinblastine
Block mitosis (cycle active), metaphase arrest.
Vincristine: remission, acute leukemia. Tx: Minimal myelosuppression (good), CNS: progressive, cumulative, weakness, tremors, convulsions
Vinblastine: solid tumors, Hodgkins disease, testicular tumors. Tx: Myelosuppression, less neuro toxicity (good).